Kamen B A, Cashmore A R, Dreyer R N, Moroson B A, Hsieh P, Bertino J R
J Biol Chem. 1980 Apr 25;255(8):3254-7.
Transport of methotrexate by L1210 sensitive and resistant cell lines was studied using [3H]methotrexate and methotrexate. The intracellular and cellular efflux of drug was analyzed by radioligand binding assay and high performance liquid chromatography. It was shown that the initial, rapid uptake of [3H]methotrexate was not methotrexate but rather [3H]p-aminobenzoylglutamate, even when the [3H]methotrexate was greater than 97% homogeneous. In the mutant cell line, the impurity could account for all of the apparent methotrexate uptake at 1 to 10 micro M extracellular drug. Similarly, the rapid efflux of [3H]methotrexate was also shown to be all, or in part, 3H-impurities, in both the mutant and sensitive cell lines. These results do not conflict with the currently accepted model of a carrier-mediated process for reduced folate and antifolate transport but do suggest that the quantitative interpretation of the early time points of transport experiments be more critically evaluated, especially when mutant cell lines are being analyzed.
使用[3H]甲氨蝶呤和甲氨蝶呤研究了L1210敏感和耐药细胞系对甲氨蝶呤的转运。通过放射性配体结合测定和高效液相色谱分析药物的细胞内摄取和细胞外排。结果表明,即使[3H]甲氨蝶呤的纯度大于97%,[3H]甲氨蝶呤的初始快速摄取物也不是甲氨蝶呤,而是[3H]对氨基苯甲酰谷氨酸。在突变细胞系中,在细胞外药物浓度为1至10微摩尔时,该杂质可解释所有明显的甲氨蝶呤摄取。同样,在突变细胞系和敏感细胞系中,[3H]甲氨蝶呤的快速外排也全部或部分是3H杂质。这些结果与目前公认的还原型叶酸和抗叶酸转运的载体介导过程模型并不冲突,但确实表明,转运实验早期时间点的定量解释需要更严格地评估,尤其是在分析突变细胞系时。